top of page
终稿.jpg

Rapid Screening of Drug-resistant Bacteria

 
 
181174-HKBU02.jpg.jpeg

About Us

 

MicroFlow Innovation Ltd. is a company grew out of a research team of Dr. Kangning Ren from Hong Kong Baptist University. We aim at bringing microfluidic techniques into the development point-of-care-tests (POCTs) and studies of drug-resistant bacteria.

Antimicrobial Resistance (AMR) is a natural phenomenon arising from the evolution of microbes, and it has escalated into one of the greatest threats to modern society. The World Health Organization (WHO) ranks AMR among the top ten global public health threats facing humanity. It poses significant risks not only to human and animal health but also to environmental sustainability, food safety, economic progress, and societal equity.

Background

Our Product

A rapid and sample-to-answer AST microfluidic system which is applicable in resource-limited conditions. Using a patented technology named barcode cell sensor, miniature bars can be formed from otherwise invisible small numbers of bacteria, realizing a microscope-free sensing at sub-macroscopic scale, largely accelerating the test. The new technology can provide information about any drug-resistant pathogens present in samples by simply using a cell phone, enabling a quick screening of samples via onsite testing within 3 hours.

image_edited_edited_edited.png
WhatsApp Image 2024-08-24 at 1_edited.pn

How's our system work?

rapid-and-cost-efficient-antimicrobial-susceptibility-testing.jpg

Our Product Strengths

~Validated to be consistent with global standards

~Rapid

~Low cost

~Portable

~Resource-independent

~User friendly

Let's Connect

Thanks for submitting!

  • Facebook
  • Twitter
  • LinkedIn

©2021 by MicroFlow Innovation. Proudly created with Wix.com

bottom of page